PAFAH1B3 and hepatocellular carcinoma: The expression of PAFAH1B3 was increased in HCC tumor tissue [18], and the effectiveness of treatment is enhanced by PAFAH1B3 blockade, which reduces the proliferation of HCC tumor cells [12, 19].